Skip to main content
. 2022 Apr 20;14(9):2062. doi: 10.3390/cancers14092062

Table 1.

Origin of the samples used in reviewed studies.

Paper Sample Acquisition Organoids/No. of Samples Country
Burgues 2007 [29] TURB 31/40 Spain
Fierabracci 2007 [30] TUR-normal bladder 6/6 Italy
Bentivegna 2010 [31] TURB 29/40 (a) Italy
Hofner 2013 [25] PDX 2/2 Germany
Okuyama 2013 [22] TURB, RC, PDX 128/152 (b) Japan
Yoshida 2015a [23] surgical resection 119/176 (b) Japan
Yoshida 2015b [24] PDX, resected, urine NA (b),(c) Japan
Gabig 2016 [26] TURB na USA
Gheibi 2017 [32] PDX, patients 6 USA
Pauli 2017 [33] Surgical resection 8/24 (d) USA
Ooki 2018 [34] PDX 2 USA
Lee 2018 [15] TURB, PDX 12/18 USA
Yoshida 2018 [35] TURB 4 USA
Neal 2018 [27] surgical resection NA (e) USA
Kita 2019 [36] TURB, PDX 6/15, 2(PDX) Japan
Mullenders 2019 [17] TURB, RC-normal and tumor 77/133 (f) Netherlands
Kim 2020 [37] TURB, RC-normal and tumor 9 South Korea
Whyard 2020 [19] TURB 4 (g) USA
Namekawa 2020 [38] TURB 2 Japan
Yoon 2020 [28] TURB 2 South Korea
Amaral 2020 [39] PDX 2 USA
Murakami 2021 [40] TURB, PDX 7 Japan
Yu 2021 [41] RC 3 China
Cai 2021 [16] PDX 2 (early & late P) USA

(a) 50 samples were collected, but only 40 had enough tissue for further processing. (b) Organoids from the same cohort of patients, here considered as one expanded cohort. (c) Missing or unclear information about number of samples. (d) Large cohort of pan-cancer organoids. Bladder and ureter organoids reported together. (e) Large cohort of pan-cancer organoids, at least one from urothelial carcinoma. (f) A total of 133 tissue samples were collected from 53 patients including normal-appearing urothelium and one or more tumor pieces per patient. (g) Two cultures, S2 and S2-1, were derived from the same line. Counted as four primary samples instead of five. TURB: transurethral resection of the bladder; RC: radical cystectomy; PDX: patient-derived xenografts; NA: information not available.